It has been shown that PDGFRA is involved in gene mutation, tumor cell proliferation, migration and invasion, maintenance of mesenchymal stromal cells (MSC), and immune infiltration, while it may serve as a potential biomarker and therapeutic target (Chang et al. 2018; Pantaleo et al. 2019; Wang et al. 2020a). Here, PDGFRA is linked to neoplasm.